Molecular genetic basis of colorectal cancer susceptibility

British Journal of Surgery

Volumn 83, Issue 3, 1996, Pages 321-329

  Cunningham, C ^a   Dunlop, M G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER SCREENING; COLORECTAL CANCER; DNA REPAIR; FAMILIAL COLON POLYPOSIS; GENE MUTATION; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DISEASE SUSCEPTIBILITY; DNA REPAIR; GENES, APC; GENETIC SCREENING; GENOTYPE; HUMANS; PEDIGREE; PHENOTYPE;

EID: 0030002476     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830309     Document Type: Review

References (78)

1. Black RJ, Sharp L, Kendrick SW, eds. Trends in Cancer Survival in Scotland, 1968-1990. Edinburgh: ISD Publications, 1993.
2. Vasen HFA, Mecklin J-P, Meera-Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-5.
3. Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med 1988; 319: 533-7.
4. Bodmer WF, Bailey CJ, Bodmer J et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328: 614-16.
5. Leppert M, Dobbs M, Scrambler P et al. The gene for familial polyposis maps to the long arm of chromosome 5. Science 1987; 238: 1411-13.
6. Groden J, Thliveris A, Samowitz W et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
7. Joslyn G, Carlson M, Thliveris A et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991; 66: 601-13.
8. Kinzler KW, Nilbert MC, Su L-K et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-5.
9. Nishisho I, Nakamura Y, Miyoshi Y et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-9.
10. Levy DB, Smith KJ, Beazer-Barclay Y, Hamilton SR, Vogelstein B, Kinzler KW. Inactivation of both APC alleles in human and mouse tumors. Cancer Res 1994; 54: 5953-8.
11. Jen J, Powell SM, Papadopoulos N et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994; 54: 5523-6.
12. Smith AJ, Stern HS, Penner M et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 1994; 54: 5527-30.
13. + in intestinal adenomas from Min mice. Cancer Res 1994; 54: 5947-52.
14. Powell SM, Zilz N, Beazer-Barclay Y et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235-7.
15. Ichii S, Takeda S, Horii A et al. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP). Oncogene 1993; 8: 2399-405.
16. Smith KJ, Johnson KA, Bryan TM et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 1993; 90: 2846-50.
17. Rubinfeld B, Souza B, Albert I et al. Association of the APC gene product with β-catenin. Science 1993; 262: 1731-4.
18. Su L-K, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734-7.
19. Munemitsu S, Souza B, Muller O, Albert I, Rubinfeld B, Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 1994; 54: 3676-81.
20. Smith KJ, Levy DB, Maupin P, Pollard TD, Vogelstein B, Kinzler KW. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res 1994; 54: 3672-5.
21. Nagase H, Nakamura Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat 1993; 2: 425-34.
22. Mandl M, Paffenholz R, Friedl W, Caspari R, Sengteller M, Propping P. Frequency of common and novel inactivating APC mutations in 202 families with familial adenomatous polyposis. Hum Mol Genet 1994; 3: 181-4.
23. Nagase H, Miyoshi Y, Horii A et al. Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients. Hum Mutat 1992; 1: 467-73.
24. Prosser J, Condie A, Wright M et al. APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis. Br J Cancer 1994; 70: 841-6.
25. Powell SM, Petersen GM, Krush AJ et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993; 329: 1982-7.
26. Su L-K, Johnson KA, Smith KJ, Hill DE, Vogelstein B, Kinzler KW. Association between wild type and mutant APC gene products. Cancer Res 1993; 53: 2728-31.
27. Spirio L, Olschwang S, Groden J et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993; 75: 951-7.
28. Caspari R, Friedl W, Mandl M et al. Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet 1994; 343: 629-32.
29. Chapman PD, Church W, Burn J, Gunn A. Congenital hypertrophy of retinal pigment epithelium: a sign of familial adenomatous polyposis. BMJ 1989; 298: 353-4.
30. Olschwang S, Tiret A, Laurent-Puig P, Muleris M, Pare R, Thomas G. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993; 75: 959-68.
31. Caspari R, Olschwang S, Friedl W et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995; 4: 337-40.
32. Hodgson SV, Bishop DT, Jay B. Genetic heterogeneity of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in families with familial adenomatous polyposis. J Med Genet 1994; 31: 55-8.
33. Paul P, Letteboer T, Gelbert L, Groden J, White R, Coppes MJ. Identical APC exon 15 mutations result in a variable phenotype in familial adenomatous polyposis. Hum Mol Genet 1993; 2: 925-31.
34. Groden J, Gelbert L, Thliveris A et al. Mutational analysis of patients with adenomatous polyposis: identical inactivating mutations in unrelated individuals. Am J Hum Genet 1993; 52: 263-72.
35. Giardiello FM, Hamilton SR, Krush AJ et al. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313-16.
36. Nicholls RJ, Springall RG, Gallagher P. Regression of rectal adenomas after colectomy and ileorectal anastomosis for familial adenomatous polyposis. BMJ 1988; 296: 1707-8.
37. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247: 322-4.
38. Dietrich WF, Lander ES, Smith JS et al. Genetic identification of Mom-1, a major modifier locus affecting Min-indueed intestinal neoplasia in the mouse. Cell 1993; 75: 631-9.
39. Dunlop MG, Wyllie AH, Steel CM, Piris J, Evans HJ. Linked DNA markers for presymptomatic diagnosis of familial adenomatous polyposis. Lancet 1991; 337: 313-16.
40. Fishel R, Lescoe MK, Rao MRS et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-38.
41. Leach FS, Nicolaides NC, Papadopolous N et al. Mutations of a MutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75: 1215-25.
42. Bronner CE, Baker SM, Morrison PT et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: 258-61.
43. Papadopoulos N, Nicolaides NC, Wei Y-F et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994; 263: 1625-9.
44. Nicolaides NC, Papadopoulos BL, Wei Y-F et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: 75-80.
45. Peltomaki P, Aaltonen LA, Sistonen P et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993; 260: 810-12.
46. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 1993; 5: 279-82.
47. Aaltonen LA, Peltomaki P, Leach FS et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-16.
48. Ionov Y, Peinado MA, Malkhosyan S, Shihata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558-61.
49. Thihodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-19.
50. Grilley M, Holmes J, Yashar B, Modrich P. Mechanisms of DNA-mismatch correction. Mutat Res 1990; 236: 253-67.
51. Strand M, Prolla TA, Liskay RM, Petes TD. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993; 365: 274-6.
52. Prolla TA, Christie D-M. Liskay RM. Dual requirement in yeast DNA mismatch repair for MLH1 and PMS1, two homologs of bacterial MutL cone. Mol Cell Biol 1994; 14: 407-15.
53. Prolla TA, Pang O, Alani E, Kolodner RD, Liskay RM. MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast. Nature 1994; 265: 1091-3.
54. Drummond JT, Li G-M, Longley MJ, Modrich P. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 1995; 268: 1909-12.
55. Palombo F, Gallinari P, Iaccarino I et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 1995; 268: 1912-14.
56. Papadopoulos N, Nicolaides NC, Liu B et al. Mutations of GTBP in genetically unstable cells. Science 1995; 268: 1915-17.
57. Lynch HT, Watson P, Smyrk TC et al. Colon cancer genetics. Cancer 1992; 70(Suppl): 1300-12.
58. Peltomaki P, Lothe RA, Aaltonen LA et al. Microsatellite instability is associated with tumours that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 1993; 53: 5853-5.
59. Aaltonen LA, Peltomaki P, Mecklin J-P et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994; 54: 1645-8.
60. Lothe RA, Peltomaki P, Meling GI et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993; 53: 5849-52.
61. Liu B, Farrington SM, Petersen GM et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Medicine 1995; 1: 348-52.
62. Carder P, Wyllie AH, Purdie CA et al. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 1993; 8: 1397-1401.
63. Liu B, Nicolaides NC, Markowitz S et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genetics 1995; 9: 48-55.
64. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 1993; 53: 5100-3.
65. Horii A, Han H-J, Shimada M et al. Frequent replication errors at microsatcllite loci in tumors of patients with multiple primary cancers. Cancer Res 1994; 54: 3373-5.
66. Wiebauer K, Jiricny J. Mismatch-specific thymine DNA glycosylasc and DNA polymerase beta mediate the correction of G.T mispairs in nuclear extracts from human cells. Proc Natl Acad Sci U S A 1990; 87: 5842-5.
67. Parsons R, Li G-M, Longley MJ et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993; 75: 1227-36.
68. Shibata D, Pcinado MA, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genetics 1994; 6: 273-81.
69. Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA 1994; 91: 6319-23.
70. Pero RW, Miller DG, Lipkin M et al. Reduced capacity for DNA repair synthesis in patients with or genetically predisposed to colorectal cancer. J Natl Cancer Inst 1983; 70: 867-75.
71. 3H]thymidine labeling patterns in colonie epithelial cells. Cancer Res 1984; 44: 4201-7.
72. Parsons R, Li G-M, Longley M et al. Mismatch repair deficiency in phenotypically normal human cells. Science 1995; 268: 738-40.
73. da Costa LT, Liu B, El-Deiry WS et al. Polymerase δ variants in RER colorectal tumours. Nature Genetics 1995; 9: 10-11.
74. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
75. Shibata L, Schaeffer J, Li Z-H, Capella G, Perucho M. Genetic heterogeneity of c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J Natl Cancer Inst 1993; 85: 1058-63.
76. Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med 1989; 329: 517-23.
77. Jarvinen HJ, Mecklin J-P, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995; 108: 1405-11.
78. Vasen HFA, Nagengast FM, Khan PM. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 1995; 345: 1183-4 (Letter).